Parameter | Value | Source |
---|---|---|
Mean number of patients in PAC per year (from 2009 to 2013) | 5688 | [11] |
Number of patients at high risk of VTE | 3583 | [11] |
Annual cost of new model of care Model 1 (existing pharmacy service) | $20,989 | |
Annual cost of new model of care Model 2 (new pharmacy service) | $154,579 - $12,741 = $141,838 | |
Appropriateness of VTE prophylaxis new model of care (%) | 100 (SE 0.01) | [11] |
Appropriateness of VTE prophylaxis usual care (%) | 91.1 (84.7–97.3) | [11] |
Probability of DVT with appropriate prophylaxis (%) | 1.6 (0.9–2.3) | [11] |
Probability of DVT with inappropriate prophylaxis (%) | 4.0 (2.7–5.3) | [11] |
Probability of PE with appropriate prophylaxis (%) | 1.1 (0.7–1.5) | [11] |
Probability of PE with inappropriate prophylaxis (%) | 2.7 (1.9–3.3) | [11] |
Probability of 12 months mortality post DVT (%) | 14.6 (14.0–15.2) | [11] |
Probability of 12 month mortality post PE (%) | 52.3 (51.5–53.1) | [11] |
Probability of 30 day mortality post DVT (%) | 5.5 (5.1–5.9) | [11] |
Probability of 30 day mortality post PE (%) | 44.4 (43.6–45.2) | [11] |
Direct cost to healthcare system of one episode of acute DVT | $10,077 | [2] |
Direct cost to healthcare system of one episode of acute PE | $10,042 | [2] |
QALYs lost post-acute episode of DVT | 0.02 (0.01–0.04) | [16] |
QALYs lost post-acute episode of PE | 0.02 (0.01–0.05) | [16] |
QALYs lost post-acute episode of DVT + 30 day death | 0.0675 () | [16] |
QALYs lost post-acute episode of PE + 30 day death | 0.0625 () | [16] |